Pharmafile Logo
Pharmafocus logo
Advanced Search

Lonza marks three plants for closure

January 14, 2010
Manufacturing and Production Lonza, facilities

Swiss chemical manufacturer Lonza will close three of its plants in Europe and the US by the end of the …

News

NICE issues schizophrenia commissioning guide

January 14, 2010
NICE, commissioning, schizophrenia

NICE has published a commissioning guide to help primary and secondary care teams recognise, treat and manage adult schizophrenia. The …

News
Resolute Kirsty

Resolute’s Kirsty Mearns promoted

January 14, 2010
Medical Communications Resolute, appointment, medical communications

Resolute has promoted Kirsty Mearns to the role of director, joining the PR agency’s board. “I am incredibly pleased and …

Appointment

Ron Branning joins Genzyme

January 14, 2010
Manufacturing and Production Genzyme, appointment, manufacturing and production

Genzyme has appointed industry veteran Ron Branning as its new senior vice president of global product quality. Branning has 30 …

Appointment

World Class Commissioning: how to be partners in quality

January 14, 2010
Sales and Marketing NHS, NHS funding, commissioning, funding, healthcare, marketing

World Class Commissioning has been heralded as a critical mechanism to revolutionise healthcare services in the UK. Now two years …

Feature

Biogen submits Fampridine PR to European regulators

January 14, 2010
Sales and Marketing Biogen, Fampridine, MS

Biogen Idec is seeking European approval for a drug which helps multiple sclerosis sufferers to walk better. A marketing authorisation …

News

Hans Regenauer joins Sanofi-Aventis’ consumer division

January 14, 2010
Sales and Marketing Sanofi-Aventis, appointment, consumer healthcare, sales and marketing

Sanofi-Aventis has appointed Han Regenauer vice president, consumer healthcare, Europe and global development. In his new role he will report …

Appointment
SWest_2009

MDS promotes Steve West to chief executive

January 14, 2010
Research and Development appointment, mds, research and development

Canadian clinical research firm MDS has appointed Steve West chief executive. He was formerly president of MDS Nordion and chief …

Appointment
GSK's swine flu vaccine Pandemrix

Germany cuts GSK swine flu vaccine orders by 30%

January 13, 2010
Sales and Marketing GlaxoSmithKline, Pandemrix, h1n1, swine flu

The Germany Ministry of Health has cut its order for GlaxoSmithKline’s swine flu vaccine Pandemrix by 30%. The pharma company …

News

FDA begins consumer transparency initiative

January 13, 2010
Research and Development, Sales and Marketing FDA, transparency

The Food and Drug Administration has unveiled the first phase of its transparency initiative, designed to make its drug approval …

News

Evonik completes handover of Tippecanoe from Lilly

January 13, 2010
Manufacturing and Production API, Evonik, lilly

Germany’s Evonik Industries has started up production of active pharmaceutical ingredients (APIs) at the Tippecanoe Laboratories facility acquired from Eli …

News
Rachel

Rachel Underwood, creative copywriter, Eurocom

January 13, 2010
Medical Communications Eurocom, appointment, medical communications

Eurocom has appointed Rachel Underwood as creative copywriter. She has over ten years of scientific and marketing communications experience and …

Appointment
Virtual 3D community Second Life

Digital Pharma: Virtual diabetes patient community launched on Second Life

January 13, 2010
Medical Communications Diabetes UK, Second Life, diabetes, digital pharma

Patient group Diabetes UK has, quite literally, set up shop on Second Life, establishing its own office in the online …

Feature

CME Spotlight: Raising the quality of published research

January 13, 2010
Medical Communications CME, CME Spotlight, Eugene Pozniak, ethics

A few years ago I met someone who worked at a car factory and he described in detail how the …

Feature

Train to retain: holding onto your best people

January 13, 2010
Business Services, Sales and Marketing MSI, careers, training

It’s a widely-held myth that retaining staff is easy in a recession. As jobs are cut the attraction of staying …

Feature

Joseph Zakrzewski, executive chairman, Amarin

January 13, 2010
Research and Development Amarin, appointment, research and development

Dublin-headquartered biotech Amarin has appointed Joseph Zakrzewski executive chairman. He is currently the chief executive of Xcellerex, a Massachusetts-based biotechnology …

Appointment

Sanofi Pasteur collaborates on novel biologics

January 12, 2010
Research and Development KaloBios, Sanofi, Sanofi Pasteur, cystic fibrosis, infection, vaccines

Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …

News

Manufacturing news in brief

January 12, 2010
Manufacturing and Production ACell, Cel-Sci, Dr Reddy's Laboratories, Genzyme, Mannkind, Pfizer, Transgene Biotek, Viva Pharmaceutical

This week’s rundown of manufacturing news includes a delay for Mannkind’s inhaled insulin product Afrezza, more job losses at Pfizer …

News

Ferring and Stiefel named and shamed for Code breaches

January 12, 2010
Medical Communications ABPI, Code of Practice, Ferring, PMCPA, Stiefel

Ferring Pharmaceuticals and Stiefel Laboratories have been named and shamed for breaching the ABPI Code of Practice. Adverts giving details …

News

Signs of product payoff from GSK’s $1.5bn alliance

January 12, 2010
Research and Development ChemoCentryx, Crohn's, GlaxoSmithKline

GlaxoSmithKline is to develop and commercialise a drug which hopes will be a treatment for moderate-to-severe Crohn’s disease. Californian biotech …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026